KēlaHealth provides a cloud-based, AI-driven surgical intelligence platform that applies patient-specific predictions, graduated care pathways, and outcomes tracking to help prevent avoidable surgical complications. The platform uses machine learning to match individual risk levels with stratified interventions across specialties including colorectal, vascular, cardiac, and orthopedics. KēlaHealth was founded by surgeon-scientists including CEO Bora Chang with clinical advisors from Duke University Health System and has participated in accelerators such as Cedars-Sinai Techstars, Healthbox Studio, and Plug and Play. The company cites a hospital partner finding up to $3 million per year in cost savings in a cardiac surgery department after applying its platform. KēlaHealth delivers its solution as a software-as-a-service to hospitals, surgeons, and health systems and plans to expand the platform to hospitals and surgical partners across the United States. The company reported closing combined seed and Series A financing to support that expansion.

Total raised

$13M

Funding rounds

2

Latest round

Seed

Latest activity

Oct 2020